retatrutide phase 3 results october 2025 TRIUMPH Top Line MEGATHREAD : r/Retatrutide Retatrutide Commercial Availability Timeline: Key

Patent estate includes the Roche structure patent agreement ($100M upfront, Jan 2026)

There is an emerging regional pattern, with Southern and Western states having the least coverage and Northeastern and Midwestern states having the most

If youd like to learn whether a supplement-centered approach could be a good fit for youeither alongside or instead of GLP-1 therapyplease use the question link above to connect with Dr Mary or call us at 717-492-0303 to schedule an in person consultation

Step 5: Begin treatment with follow-up

Therefore, the combined use of GLP-1 RAs with therapies targeting intrahepatic pathways, such as thyroid hormone receptor (THR-) agonists, fibroblast growth factor-21 (FGF21) analogues, and peroxisome proliferator-activated receptor (PPAR) agonists, presents a promising approach for MASH treatment

Clin Exp Allergy (2017) 47(3):3318